Yidao Biotechnology
Suzhou
About Yidao Biotechnology
Yidao Biotechnology research and develops vaccines and biomedical products. It focuses on the research and development of a variety of vaccines such as recombinant protein antigen vaccine, new virus vector vaccine, messenger RNA vaccine, and vaccine adjuvant platforms, providing vaccines to meet the needs of human health in both domestic and international markets. The Suzhou, Jiangsu-based biotech company was established in 2017.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $87.0M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2024)
- Website: immune-path.com
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical, Product Research
Canonical: https://fsome.com/organization/yidao-biotechnology-6416 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.